MLN8054

MLN8054

Catalog Number:
L002369026APE
Mfr. No.:
APE-A4114
Price:
$276
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          MLN8054 is a potent of Aurora A kinase (AAK) inhibitor consisting of a benzazepine core scaffold with a fused amino pyrimidine and an aryl carboxylic acid which represents an unprecedented kinase inhibitor framework. The inhibition of MLN8054 towards AAK is ATP-competitive, reversible and selective with an IC50 value of 4nM, which is more than 40-fold and 100-fold selective comparing to Aurora B kinase (IC50 = 175 nM) and a range of other kinases respectively. MLN8054 exerts antitumor activity against human tumor xenografts through AAK inhibition, which results in deactivation of Pt288, spindle defects, accumulation of G2/M, and apoptosis-induced cell death in tumor cells.

      • Properties
        • Alternative Name
          4-[[9-chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid
          CAS Number
          869363-13-3
          Molecular Formula
          C25H15ClF2N4O2
          Molecular Weight
          476.86
          Purity
          98.00%
          Solubility
          insoluble in EtOH; insoluble in H2O; ≥39.05 mg/mL in DMSO
          Storage
          Store at -20°C

          * For Research Use Only

    We Also Recommend

    AT9283

    $260

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.